{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:15:07Z","timestamp":1784542507170,"version":"3.55.0"},"reference-count":29,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,8,30]],"date-time":"2022-08-30T00:00:00Z","timestamp":1661817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JoF"],"abstract":"<jats:p>The COVID-19 pandemic is associated with a significant increase in the incidence of invasive mycosis, including pulmonary aspergillosis, mucormycosis, and candidiasis. Fungal empyema thoracis (FET) is an uncommon clinical presentation of invasive fungal disease (IFD) associated with significant mortality. Here, we describe the first report of a patient with post-COVID-19 multifocal necrotizing pneumonia complicated by a polymicrobial empyema that included Candida glabrata. Candida empyemas represent another manifestation of a COVID-19-associated fungal opportunistic infection, and this infrequently encountered entity requires a high degree of clinical suspicion for timely identification and management. Therapy for empyemas and other non-bloodstream Candida infections may differ from candidemia due to several pharmacokinetic parameters impacting bioavailability of the antifungal in the affected tissue (e.g., pleural space) and is an area that needs more investigation.<\/jats:p>","DOI":"10.3390\/jof8090923","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T00:13:56Z","timestamp":1661904836000},"page":"923","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Candida glabrata Empyema Thoracis\u2014A Post-COVID-19 Complication"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9043-0420","authenticated-orcid":false,"given":"Neeraja","family":"Swaminathan","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Anderson","sequence":"additional","affiliation":[{"name":"Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9905-5754","authenticated-orcid":false,"given":"Joshua D.","family":"Nosanchuk","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-3083","authenticated-orcid":false,"given":"Matthew J.","family":"Akiyama","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Infectious Diseases, Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY 10467, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,8,30]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., Nguyen, M.H., Hedayati, M.T., Netea, M.G., Perlin, D.S., and Hoenigl, M. (2020). COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of immunological predispositions?. J. Fungi, 6, Available online: https:\/\/pubmed.ncbi.nlm.nih.gov\/33050019\/.","DOI":"10.3390\/jof6040211"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"ofaa656","DOI":"10.1093\/ofid\/ofaa656","article-title":"Candida empyema thoracis at two academic medical centers: New insights into treatment and outcomes","volume":"8","author":"Senger","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.4103\/ijmm.IJMM_20_112","article-title":"Candidaemia in a tertiary care centre of developing country: Monitoring possible change in spectrum of agents and antifungal susceptibility","volume":"38","author":"Kaur","year":"2020","journal-title":"Indian J. Med. Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1473-3099(20)30086-4","article-title":"Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: A descriptive study","volume":"20","author":"Shi","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cid\/civ1194","article-title":"Executive summary: Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/imj.15589","article-title":"Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021","volume":"51","author":"Keighley","year":"2021","journal-title":"Intern. Med. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jinf.2016.02.014","article-title":"Fungal empyema thoracis in cancer patients","volume":"72","author":"Nigo","year":"2016","journal-title":"J. Infect."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jmii.2012.08.010","article-title":"Report of a 63-case series of Candida empyema thoracis: 9-year experience of two medical centers in central Taiwan","volume":"47","author":"Lin","year":"2014","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1378\/chest.117.6.1672","article-title":"Fungal empyema thoracis: An emerging clinical entity","volume":"117","author":"Ko","year":"2000","journal-title":"Chest"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1128\/CMR.00046-13","article-title":"Tissue penetration of antifungal agents","volume":"27","author":"Felton","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1128\/AAC.01560-10","article-title":"Pharmacokinetics of anidulafungin in pleural fluid during the treatment of a patient with Candida empyema","volume":"55","author":"Moriyama","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/BF02113615","article-title":"Fluconazole concentrations in pulmonary tissue and pericardial fluid","volume":"25","author":"Hasse","year":"1997","journal-title":"Infection"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mulet Bayona, J.V., Salvador Garc\u00eda, C., Tormo Palop, N., Valent\u00edn Mart\u00edn, A., Gonz\u00e1lez Padr\u00f3n, C., Colomina Rodr\u00edguez, J., Peman, J., and Gimeno Cardona, C. (2022). Novel chromogenic medium CHROMagarTM Candida Plus for detection of Candida auris and other Candida species from surveillance and environmental samples: A multicenter study. J. Fungi, 8.","DOI":"10.3390\/jof8030281"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1476-0711-5-1","article-title":"Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida","volume":"5","author":"Hospenthal","year":"2006","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.1128\/JCM.01581-13","article-title":"Comparative Evaluation of BD Phoenix and Vitek 2 Systems for Species Identification of Common and Uncommon Pathogenic Yeasts","volume":"51","author":"Posteraro","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1128\/JCM.00802-15","article-title":"Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy","volume":"53","author":"Posteraro","year":"2015","journal-title":"J. Clin. Microbiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jalm\/jfac005","article-title":"Evaluation of MALDI-TOF MS for identification of species in the Candida parapsilosis complex from candidiasis cases","volume":"7","author":"Samantaray","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"BSR20190859","DOI":"10.1042\/BSR20190859","article-title":"Accuracy of matrix-assisted LASER desorption ionization-time of flight mass spectrometry for identification of Candida","volume":"39","author":"Xie","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1080\/13693780802342552","article-title":"A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser","volume":"46","author":"Vervaeke","year":"2008","journal-title":"Med. Mycol."},{"key":"ref_20","first-page":"1846","article-title":"Candida lambica polyarthritis in a patient with chronic alcoholism","volume":"26","author":"Trowbridge","year":"1999","journal-title":"J. Rheumatol."},{"key":"ref_21","first-page":"S10","article-title":"Treatment of mycotic infections after haemopoietic progenitor cell transplantation with liposomal amphotericin-B","volume":"22","author":"Renges","year":"1998","journal-title":"Bone Marrow Transplant."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.3201\/eid2704.204895","article-title":"COVID-19-Associated Pulmonary Aspergillosis, March-August 2020","volume":"27","author":"Sprute","year":"2021","journal-title":"Emerg. Infect. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/QCO.0000000000000812","article-title":"Invasive aspergillosis in coronavirus disease 2019: A practical approach for clinicians","volume":"35","author":"Lamoth","year":"2022","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Chandley, P., Subba, P., and Rohatgi, S. (2022). COVID-19-Associated Mucormycosis: A Matter of Concern Amid the SARS-CoV-2 Pandemic. Vaccines, 10.","DOI":"10.3390\/vaccines10081266"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/myc.13471","article-title":"Global prevalence and subgroup analyses of coronavirus disease (COVID-19) associated Candida auris infections (CACa): A systematic review and meta-analysis","volume":"65","author":"Vaseghi","year":"2022","journal-title":"Mycoses"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"105520","DOI":"10.1016\/j.micpath.2022.105520","article-title":"Clinical Impact of Candida Respiratory Tract Colonization and Acute Lung Infections in Critically Ill Patients with COVID-19 Pneumonia","volume":"166","author":"Erami","year":"2022","journal-title":"Microb. Pathog."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"A717","DOI":"10.1016\/j.chest.2020.08.673","article-title":"A tale of two species: First reported case of an empyema secondary to co-infection with SARS-CoV-2 and candida albicans","volume":"158","author":"Sharma","year":"2020","journal-title":"Chest"},{"key":"ref_28","first-page":"10","article-title":"Candida albicans empyema in COVID-19 infected patient: The first reported case in Qatar","volume":"2022","author":"Qasem","year":"2022","journal-title":"J. Emerg. Med. Trauma Acute Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"A566","DOI":"10.1016\/j.chest.2020.08.532","article-title":"A Report of Fungal Empyema Following Recovery of Severe SARS-CoV-2 Infection","volume":"158","author":"Glendening","year":"2020","journal-title":"Chest"}],"container-title":["Journal of Fungi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/9\/923\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:20:39Z","timestamp":1760142039000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2309-608X\/8\/9\/923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,30]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["jof8090923"],"URL":"https:\/\/doi.org\/10.3390\/jof8090923","relation":{},"ISSN":["2309-608X"],"issn-type":[{"value":"2309-608X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,30]]}}}